F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure that drugs and biologicals used in the facility were
secured properly for 1 of 5 (Resident #1) residents in that:
1. LVN A failed to ensure medications for Resident #1 were secure when she left Resident #1's medications
in a cup on the bedside table and walked out of the room.
This failure could place residents at risk for harm and result in drug diversion due to medications not being
properly secured.
Findings included:
1. Record review of Resident #1's undated face sheet revealed a [AGE] year-old female admitted to the
facility on [DATE] with the following diagnoses: Atherosclerotic Heart Disease (buildup of plaque in the
arteries), Paroxysmal Atrial Fibrillation (rapid, irregular heartbeat that lasts a few hours or days),
Hypertension (high blood pressure), Anxiety, Gastro-Esophageal Reflux Disease (digestive condition in
which the stomach contents move up into the esophagus), Altered Mental Status (change in mental
function), and Age-Related Cognitive Decline (difficulty with thinking, memory and concentration).
Record review of Resident #1's annual MDS dated [DATE] revealed a BIMS score of 10, indicating
moderate cognitive impairment.
Record review of Resident #1's current Physician's orders revealed the following orders: Buspirone tablet;
10 mg; amt: 1 oral. Three times a day 08:00 AM, 12:00 PM, 07:00 AM with a start date 09/17/24. Colace
(docusate sodium) [OTC] capsule; 100 mg; amt: 1; oral. Once a day 08:00 AM with a start date of 02/26/24.
Diltiazem HCl capsule, extended release; 240 mg; amt: 1 cap; oral; once a day 08:00 AM with a start date
of 11/08/24. Lisinopril tablet; 10 mg; amt: 1; oral. Once a day 08:00 AM with a start date of 10/09/24.
Omeprazole capsule, delayed release; 20 mg; amt: 1; oral. Once a day 08:00 AM with a start date of 08:00
AM. Prednisone tablet; 5 mg; amt: 1; oral. Once a day 08:00 AM with a start date of 10/09/24. Xarelto
(rivaroxaban) tablet; 20 mg; amt: 1 tab; oral. Once a day 08:00 AM.
Record review of Resident #1's MAR dated 01/21/25 revealed the resident received medications on
01/18/25, according to Physician's orders to include the following: Buspirone tablet; 10 mg; amt: 1 oral.
Three times a day 08:00 AM, 12:00 PM, 07:00 AM with a start date 09/17/24. Colace (docusate sodium)
[OTC] capsule; 100 mg; amt: 1; oral. Once a day 08:00 AM with a start date of 02/26/24. Diltiazem
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
675014
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675014
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/21/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Avir at Haskell
1504 North First St
Haskell, TX 79521
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
HCl capsule, extended release; 240 mg; amt: 1 cap; oral; once a day 08:00 AM with a start date of
11/08/24. Lisinopril tablet; 10 mg; amt: 1; oral. Once a day 08:00 AM with a start date of 10/09/24.
Omeprazole capsule, delayed release; 20 mg; amt: 1; oral. Once a day 08:00 AM with a start date of 08:00
AM. Prednisone tablet; 5 mg; amt: 1; oral. Once a day 08:00 AM with a start date of 10/09/24. Xarelto
(rivaroxaban) tablet; 20 mg; amt: 1 tab; oral. Once a day 08:00 AM.
Residents Affected - Few
During a phone interview on 01/21/25 at 4:47 PM, LVN A stated she worked weekends at the facility. She
stated she was at work on 01/18/25 and was scheduled to work from 06:00 AM to 06:00 PM that day. LVN
A stated she was passing medications on hall 3 between approximately 07:30 AM and 08:30 AM and she
parked the medication cart outside Resident #1's room. She stated she dispensed Resident #1's morning
medications into a medication cup and took the medications in to Resident #1. She stated Resident #1 did
not like to be rushed and preferred to take her medications one at a time while she visited with staff. LVN A
stated, while in Resident #1's room, another resident across the hall called for assistance. She stated
Resident #1 had not taken any of her medications yet and she left the cup of medications on Resident #1's
bedside table, left the door open and walked across the hall to check on the resident who called for
assistance. LVN A stated she thought she would be gone from Resident #1's room briefly but the interaction
with the other resident took longer than she expected. She stated she was gone from Resident #1's room
for approximately five to ten minutes. She stated she re-entered Resident #1's room and observed Resident
#1 holding the cup of medications. She stated she observed Resident#1 take each medication in the cup
one-by-one. She stated she then made sure the resident was comfortable and exited the room. LVN A
stated she should not have left the cup of medications unattended in the room, even briefly. She stated she
should have taken the cup of medications with her and locked them in the medication cart when she left the
room to check on another resident.
During a follow-up phone interview on 01/21/25 at 05:14 PM, LVN A stated she had been trained to witness
a resident take all dispensed medications prior to leaving the room and signing the MAR. LVN A stated she
had been trained on proper medication storage and administration through quarterly in services and
through medication pass observations conducted by the ADON. She stated a potential negative outcome
for leaving medications unsupervised and unsecured would be that the resident may drop a medication,
which would result in not receiving medications as ordered by the physician.
During an interview on 01/21/25 at 05:47 PM, the DON stated he was not aware that medications had been
left unsupervised by LVN A on 01/18/25. He stated LVN A should not have left medications unsupervised in
a resident room. He stated she should have put the medications back in the cart and locked the cart. He
stated all staff had been trained not to leave a resident unattended with medications. The DON stated staff
were trained on proper medication storage and administration through annual skills checks and quarterly
medication administration observations conducted by the pharmacy consultant. He stated a potential
negative outcome for failure to properly secure medications would be the resident could miss a dose or
another resident could take medication that was not ordered for them.
Record review of a facility training document titled Licensed Nurse Proficiency Audit, dated 05/03/24,
revealed LVN A's name and satisfactory was checked for the skill administers medication properly.
Record review of the facility-provided policy titled Medication Administration - Orals, dated 2007 revealed:
Policy
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675014
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675014
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/21/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Avir at Haskell
1504 North First St
Haskell, TX 79521
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
To administer oral medications in an organized, accurate and safe manner.
Level of Harm - Minimal harm
or potential for actual harm
Procedures
.
Residents Affected - Few
10. administer medication and remain with resident while medication is swallowed. Do not leave a
medication in a resident's room without orders to do so along with documentation of self-administration.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675014
If continuation sheet
Page 3 of 3